Results 71 to 80 of about 581 (153)

Solriamfetol improves daily fatigue symptoms in adults with myalgic encephalomyelitis/chronic fatigue syndrome after eight weeks of treatment

Background: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a long-term illness with no treatment options that address the disease directly.
Joel Young, Richard Powell, Anna Powell, Lisa Welling, Lauren Granata, Jamie Saal   +5 more
core   +1 more source

Solriamfetol for treating excessive sleepiness caused by narcolepsy: a Single Technology Appraisal

, 2020
This report is a critique of the company submission (CS) to NICE from Jazz Pharmaceuticals on the clinical effectiveness and cost effectiveness of solriamfetol for treating excessive daytime sleepiness caused by narcolepsy.
Lord, Joanne, Scott, David Alexander, Hazell, Lorna, Tikhonova, Irina, Shepherd, Jonathan, Onyimadu, Oluchukwu O, Picot, Joanna   +6 more
core   +1 more source

SOLRIAMFETOL ON COGNITION IN OBSTRUCTIVE SLEEP APNEA WITH EXCESSIVE DAYTIME SLEEPINESS AND IMPAIRED COGNITION

Introduction: Cognitive impairment is a burdensome symptom in many patients with excessive daytime sleepiness (EDS) associated with obstructive sleep apnea (OSA).
Drake, Christopher, Eglit, Graham, Bogan, Richard, Van Dongen, Hans, Leary, Eileen, Jaeger, Judith   +5 more
core   +1 more source

Pharmacological Interventions for Excessive Daytime Sleepiness in Adults with Narcolepsy: A Systematic Review and Network Meta-Analysis

, 2022
Narcolepsy is a neurological disease characterized by a core symptom of excessive daytime sleepiness (EDS). Although effective pharmacological interventions for narcolepsy have been developed, a lack of comparative evidence supporting the relative ...
Meng-Hsuan Lin, Po-Yu Chien, Chan-Yen Kuo, Yao-Jen Chang, Chien, Po-Yu, Chang, Yao-Jen, Lin, Meng-Hsuan, Kuo, Chan-Yen, Hung, Chin-Chuan, Chin-Chuan Hung   +9 more
core   +1 more source

Solriamfetol Suppresses Inflammation and Fibrosis via Adenosine Deaminase Inhibition in a Murine Model of an Idiopathic Pulmonary Fibrotic Disease

Background: Solriamfetol, a dopamine and norepinephrine reuptake inhibitor widely used in narcolepsy management, has not been thoroughly investigated for its anti-fibrotic and anti-inflammatory properties.
Shinkyu Choi, Ji Aee Kim, Suk Hyo Suh, Kwan-Chang Kim   +3 more
core   +1 more source

Solriamfetol Titration & AdministRaTion (START): Characteristics of Patients with Obstructive Sleep Apnoea and Prescriber Rationale for Starting Treatment with Solriamfetol [PDF]

Pneumologie, 2021
H. Singh, D. Hyman, G.S. Parks, A. Chen, C. Foley, D. Ito, M.J. Thorpy   +6 more
openaire   +1 more source

Solriamfetol for treating excessive daytime sleepiness caused by obstructive sleep apnoea: a Single Technology Appraisal

, 2020
This report is a critique of the company's submission (CS) to NICE from Jazz Pharmaceuticals on the clinical effectiveness and cost effectiveness of solriamfetol for treating excessive daytime sleepiness caused by obstructive sleep apnoea.
Lord, Joanne, Hazell, Lorna, Tikhonova, Irina, Shepherd, Jonathan, Onyimadu, Oluchukwu O, Picot, Joanna   +5 more
core   +1 more source

suppl._mat – Supplemental material for A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor

, 2018
Supplemental material, suppl._mat for A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor by Lawrence P Carter, Jack E ...
Jack E Henningfield (5810291), Yuan Lu (249915), Debra Kelsh (5810297), Lawrence P Carter (5810288), Edward Sellers (5810303), Y Grace Wang (5810294), Bradley Vince (5810300)   +6 more
core   +1 more source

Daily solriamfetol improved performance on a memory and attention task in people with obstructive sleep apnea and excessive daytime sleepiness: a plain language summary

What is this summary about? The SHARP study looked at the effects of a medication called solriamfetol in people with obstructive sleep apnea (sleep apnea for short) who were very sleepy during the day (called excessive daytime sleepiness) and had trouble
Tabuteau, Herriot, Van Dongen, Hans P. A., Bogan, Richard, Jaeger, Judith, Leary, Eileen B, Drake, Christopher L, Streicher, Caroline   +6 more
core   +1 more source

Results of the Solriamfetol\u27s Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-Controlled Study (SHARP): A Randomized Placebo-Controlled Double-Blind Repeated-Measures Crossover Phase IV Clinical Trial of the Effect of the Wake-Promoting Agent Solriamfetol on Cognitive Function in OSA With Excessive Daytime Sleepiness and Cognitive Impairment

BACKGROUND: OSA causes episodes of fragmented sleep and intermittent hypoxia and leads to excessive daytime sleepiness (EDS). Deficits in cognitive function are a troublesome symptom in patients with OSA and EDS.
Tabuteau, Herriot, Rosenberg, Russell, Van Dongen, Hans P. A., Drake, Christopher, Bogan, Richard, Jaeger, Judith, Leary, Eileen B, Streicher, Caroline   +7 more
core   +3 more sources